4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-17-013940
CIK 0001328143operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:38 PM ET
Size
9.8 KB
Accession
0001209191-17-013940
Insider Transaction Report
Form 4
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
- Award
Common Stock
2017-02-21+23,125→ 169,333 total - Award
Stock Option (Right to Buy)
2017-02-21+138,750→ 138,750 totalExercise: $17.20Exp: 2027-02-20→ Common Stock (138,750 underlying)
Holdings
- 80,000(indirect: By Trust)
Common Stock
- 80,000(indirect: By Trust)
Common Stock
- 195,392(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2018, March 20, 2019, March 20, 2020 and March 20, 2021, subject to Reporting Person's Continuous Service as of each such date.
- [F2]The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2017, subject to Reporting Person's Continuous Service as of each such date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:38 PM ET
- Size
- 9.8 KB